LIGAND PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ligand Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Ligand Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 18.9M shares, a 8.37% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 18.9M +1.46M +8.37% Nov 5, 2024 10-Q 2024-11-08
Q2 2024 18.3M +914K +5.27% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 17.7M +433K +2.51% Feb 26, 2024 10-K 2024-02-29
Q3 2023 17.4M +542K +3.21% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 17.4M +473K +2.8% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 17.3M +411K +2.44% May 4, 2023 10-Q 2023-05-08
Q3 2022 16.9M +182K +1.09% Nov 4, 2022 10-Q 2022-11-08
Q2 2022 16.9M +206K +1.24% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 16.9M +209K +1.26% May 5, 2022 10-Q 2022-05-09
Q3 2021 16.7M +620K +3.86% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 16.7M +598K +3.72% Jul 30, 2021 10-Q 2021-08-03
Q1 2021 16.7M +602K +3.75% May 3, 2021 10-Q 2021-05-06
Q3 2020 16.1M -1.47M -8.38% Nov 3, 2020 10-Q 2020-11-06
Q2 2020 16.1M -2.93M -15.4% Aug 4, 2020 10-Q 2020-08-07
Q1 2020 16M -4.4M -21.5% May 5, 2020 10-Q 2020-05-08
Q3 2019 17.6M -3.69M -17.4% Nov 6, 2019 10-Q 2019-11-08
Q2 2019 19M -2.09M -9.92% Aug 7, 2019 10-Q 2019-08-08
Q1 2019 20.4M -856K -4.02% Feb 25, 2019 10-K 2019-02-28
Q3 2018 21.3M +148K +0.7% Nov 6, 2018 10-Q 2018-11-08
Q2 2018 21.1M +50.3K +0.24% Aug 7, 2018 10-Q 2018-08-08
Q1 2018 21.3M +305K +1.45% Apr 20, 2018 10-Q 2018-05-09
Q3 2017 21.1M +205K +0.98% Oct 31, 2017 10-Q 2017-11-09
Q2 2017 21.1M +199K +0.96% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 21M +174K +0.83% May 1, 2017 10-Q 2017-05-09
Q4 2016 20.9M Feb 9, 2017 10-K 2017-02-28
Q3 2016 20.9M +974K +4.89% Nov 1, 2016 10-Q 2016-11-15
Q2 2016 20.9M +1M +5.03% Aug 1, 2016 10-Q/A 2016-11-15
Q1 2016 20.8M +1.16M +5.88% May 1, 2016 10-Q/A 2016-11-15
Q3 2015 19.9M -97.4K -0.49% Nov 7, 2015 10-Q 2015-11-09
Q2 2015 19.9M -926K -4.46% Aug 1, 2015 10-Q 2015-08-05
Q1 2015 19.7M -1.06M -5.11% May 1, 2015 10-Q 2015-05-11
Q4 2014 19.6M -969K -4.7% Dec 12, 2014 10-K/A 2014-12-12
Q3 2014 20M -387K -1.9% Oct 31, 2014 10-Q 2014-10-31
Q2 2014 20.8M +340K +1.66% Aug 5, 2014 10-Q 2014-08-05
Q1 2014 20.7M +517K +2.56% May 7, 2014 10-Q 2014-05-07
Q4 2013 20.6M Feb 14, 2014 10-K/A 2014-12-01
Q3 2013 20.4M +446K +2.23% Oct 29, 2013 10-Q 2013-11-08
Q2 2013 20.4M +504K +2.53% Aug 1, 2013 10-Q 2013-08-01
Q1 2013 20.2M +474K +2.4% Mar 1, 2013 10-K 2013-03-14
Q3 2012 20M +291K +1.48% Nov 6, 2012 10-Q 2012-11-14
Q2 2012 19.9M +264K +1.34% Aug 8, 2012 10-Q/A 2012-11-14
Q1 2012 19.7M Apr 30, 2012 10-Q/A 2012-11-14
Q4 2011 19.7M Feb 1, 2012 10-K/A 2012-11-14
Q3 2011 19.7M Nov 4, 2011 10-Q/A 2012-02-10
Q2 2011 19.7M Aug 1, 2011 10-Q/A 2012-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.